Related references
Note: Only part of the references are listed.Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M. Molinaro et al.
JAMA ONCOLOGY (2020)
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M. Miller et al.
NATURE (2019)
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
V. Rimelen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes et al.
BLOOD (2019)
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A. Bale et al.
NEURO-ONCOLOGY (2019)
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
Naema Nayyar et al.
BLOOD ADVANCES (2019)
MYD88 L265P Mutation in Lymphoid Malignancies
Xinfang Yu et al.
CANCER RESEARCH (2018)
Genotype-targeted local therapy of glioma
Ganesh M. Shankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Diagnosis and Management of Primary Central Nervous System Lymphoma
Catherine H. Han et al.
CANCER (2017)
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme
R. Cerqua et al.
NEUROLOGICAL SCIENCES (2016)
Accuracy of Flow Cytometry and Cytomorphology for the Diagnosis of Meningeal Involvement in Lymphoid Neoplasms: A Systematic Review
Simone Canovi et al.
DIAGNOSTIC CYTOPATHOLOGY (2016)
TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium
Aurelie Bruno et al.
ACTA NEUROPATHOLOGICA (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)